Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744848 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy
A Phase 3 study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 204
- Enrollment target
NCT00744848 is a Phase 3 study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 204 participants.
The verdict
NCT00744848, a Phase 3 study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 204 participants
- Enrollment target
Study Summary
Effective postoperative pain control to promote improved healing, faster patient mobilization, shortened hospital stays, and reduced healthcare costs.
Interventions
- DRUG Bupivacaine HCl
- DRUG SKY0402
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00744848
The ClinicalTrials.gov registry entry for NCT00744848 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine HCl is the first listed.
NCT00744848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00744848 about?
NCT00744848 is a clinical study titled "Study to Evaluate Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy". Effective postoperative pain control to promote improved healing, faster patient mobilization, shortened hospital stays, and reduced healthcare costs.
What is the current status of trial NCT00744848?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 204 participants. The study started on 2008-08. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00744848?
The interventions under investigation include: Bupivacaine HCl (DRUG), SKY0402 (DRUG).
Who is sponsoring clinical trial NCT00744848?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.